MSK Westchester is a clinical research site located in Harrison, New York, United States 10604.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
MSK Westchester has participated in 13 clinical trials with 7 currently active.
Therapeutic areas: Multiple Myeloma, Advanced Malignancies, NSCLC.
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer, Hoffmann-La Roche.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
MSK Westchester has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MSK Westchester has 13 clinical trials on record, with 7 currently active. Their work covers Multiple Myeloma, Advanced Malignancies, NSCLC.
Yes — MSK Westchester holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.